UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carcinome hépatocellulaire : nous sommes à l’aube d’une nouvelle époque

Oncologie (Paris, France), 2017-06, Vol.19 (5-6), p.133-134

Raoul, J. -L.

2017

Volltextzugriff (PDF)

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

Cancer treatment reviews, 2011-05, Vol.37 (3), p.212-220

2011

Volltextzugriff (PDF)

Carcinome hépatocellulaire : quels soins de confort ?

Oncologie (Paris, France), 2017-06, Vol.19 (5-6), p.184-187

2017

Volltextzugriff (PDF)

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Annals of oncology, 2017-02, Vol.28 (2), p.339-343

2017

Volltextzugriff (PDF)

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

Annals of oncology, 2009-04, Vol.20 (4), p.674-680

2009

Volltextzugriff (PDF)

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Annals of oncology, 2012-11, Vol.23 (11), p.2799-2805

2012

Volltextzugriff (PDF)

Use of chemotherapy near the end of life: what factors matter?

Annals of oncology, 2017-04, Vol.28 (4), p.809-817

2017

Volltextzugriff (PDF)

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009

Annals of oncology, 2010-08, Vol.21 (8), p.1579-1584

2010

Volltextzugriff (PDF)

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

European journal of cancer (1990), 2017-10, Vol.84, p.239-249

2017

Volltextzugriff (PDF)

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

European journal of cancer (1990), 2013-01, Vol.49 (1), p.90-97

2013

Volltextzugriff (PDF)

Folfox and intra-arterial DEBIRI as front-line treatment in patients with non resectable colorectal cancer liver metastases (FFCD 1201 phase II trial)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii153

2018

Volltextzugriff (PDF)

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

European journal of cancer (1990), 2018-11, Vol.104, p.108-116

2018

Volltextzugriff (PDF)

Practice patterns, radiologic tumor response, and deterioration of liver function after transarterial chemoembolization (TACE): Final analysis of OPTIMIS in Korea and other regions

Annals of oncology, 2018-11, Vol.29, p.ix47-ix48

2018

Volltextzugriff (PDF)

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

British journal of cancer, 2007-10, Vol.97 (7), p.862-867

2007

Volltextzugriff (PDF)

Practice patterns and deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Final analysis of OPTIMIS in Europe and Canada

Annals of oncology, 2018-10, Vol.29, p.viii240-viii240

2018

Volltextzugriff (PDF)

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

Annals of oncology, 2008-06, Vol.19 (6), p.1117-1126

2008

Volltextzugriff (PDF)

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Annals of oncology, 2002-08, Vol.13 (8), p.1185-1191

2002

Volltextzugriff (PDF)

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

British journal of cancer, 2010-10, Vol.103 (9), p.1349-1355

2010

Volltextzugriff (PDF)

Cancer du pancréas exocrine : compte rendu anatomopathologique type en 2015

Oncologie (Paris, France), 2015-11, Vol.17 (11-12), p.500-504

2015

Volltextzugriff (PDF)

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Annals of oncology, 2017-09, Vol.28 (9), p.2149-2159

2017

Volltextzugriff (PDF)

Medical oncologists must get more involved in systemic treatment of hepatocellular carcinoma

Annals of oncology, 2019-01, Vol.30 (1), p.6-8

2019

Volltextzugriff (PDF)

Chimioembolisation et hépatocarcinome: pour quel type de patient ?

Oncologie (Paris, France), 2012-03, Vol.14 (3), p.174-178

2012

Volltextzugriff (PDF)

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

British journal of cancer, 2006-09, Vol.95 (6), p.705-709

2006

Volltextzugriff (PDF)

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

ESMO open, 2023-02, Vol.8 (1), p.100880-100880, Article 100880

2023

Volltextzugriff (PDF)

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)

Digestive and liver disease, 2023-12, Vol.55 (12), p.1583-1601

2023

Volltextzugriff (PDF)

1 – 25 von 4.811

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.656)
Mit Volltextzugriff
(3.939)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB*
(2.094)
JSTOR
(969)
Ingenta E-Journals
(937)
MEDLINE
(827)
NUS Single-Journal Subscriptions
(757)
Journals@Ovid Full Text
(509)
Elsevier ScienceDirect Journals Complete
(483)
IngentaConnect Journals
(414)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(249)
Wiley Online Library
(206)
Wiley Online Library Full Collection 2018
(165)
Springer journals
(123)
ProQuest Dissertations & Theses A&I
(104)
Nexis Uni
(100)
Taylor & Francis:Master (3349 titles)
(96)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(89)
Oxford journals
(63)
Nature
(57)
Taylor & Francis Journals
(57)
Ebook Central Perpetual and DDA
(51)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Carcinome hépatocellulaire : nous sommes à l’aube d’une nouvelle époque

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

Carcinome hépatocellulaire : quels soins de confort ?

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Use of chemotherapy near the end of life: what factors matter?

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

Folfox and intra-arterial DEBIRI as front-line treatment in patients with non resectable colorectal cancer liver metastases (FFCD 1201 phase II trial)

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

Practice patterns, radiologic tumor response, and deterioration of liver function after transarterial chemoembolization (TACE): Final analysis of OPTIMIS in Korea and other regions

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

Practice patterns and deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Final analysis of OPTIMIS in Europe and Canada

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

Cancer du pancréas exocrine : compte rendu anatomopathologique type en 2015

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Medical oncologists must get more involved in systemic treatment of hepatocellular carcinoma

Chimioembolisation et hépatocarcinome: pour quel type de patient ?

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)

Suchergebnisse filtern